Global Benchmark for Efficient Drug Pricing (GLOBE) Model
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Dec. 23, 2025. Document 2025-23702. Updated Nov. 16, 2026.
- What it does
This proposed rule proposes to implement the Global Benchmark for Efficient Drug Pricing Model ("GLOBE Model"), a new Medicare payment model under section 1115A of the Social Security Act (the Act). The GLOBE Model would test whether a payment model that uses an alternative method for calculating Part B inflation rebate amounts for certain separately payable Part B drugs and biologicals products reduces costs for Medicare fee-for-service (FFS) beneficiaries and the Medicare program while preserving quality of care.
The Centers for Medicare & Medicaid Services's summary, as published in the Federal Register.
- What it would change
1 part of Title 42 of the Code of Federal Regulations:
- Before this
No earlier Federal Register document under regulation identifier 0938-AV66 since Jan. 1, 2025.
Since then:
- What happens next and when
To be assured consideration, comments must be received at one of the addresses provided below, by February 23, 2026.
The agency's dates, word for word.
The record as published
| Document number | 2025-23702 |
|---|---|
| Action | Proposed rule. |
| Agencies | Health and Human Services Department; Centers for Medicare & Medicaid Services |
| Published | Dec. 23, 2025 |
| Comments close | Feb. 23, 2026 |
| Regulation identifier (RIN) | 0938-AV66 |
| Docket | CMS-2025-1889 |
| Significant (marked in the Federal Register) | Yes |
Source: the Federal Register (public domain). The document in the Federal Register